Exploiting the Full Potential of Beta-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Henryk Barthel; John Seibyl; Adriaan A. Lammertsma; Victor L Villemagne; Osama Sabri

doi:10.2967/jnumed.119.228346

OtherHot Topics (Invitation Only)

Exploiting the Full Potential of Beta-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Henryk Barthel, John Seibyl, Adriaan A. Lammertsma, Victor L Villemagne and Osama Sabri

Journal of Nuclear Medicine May 2020, jnumed.119.228346; DOI: https://doi.org/10.2967/jnumed.119.228346

Henryk Barthel

1 Leipzig University, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John Seibyl

2 Institute for Neurodegenerative Disorders;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Adriaan A. Lammertsma

3 VU University Medical Center;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Victor L Villemagne

4 Austin Hospital, The University of Melbourne;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Osama Sabri

5 University Hospital Leipzig

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 64, Issue 2

February 1, 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Exploiting the Full Potential of Beta-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Exploiting the Full Potential of Beta-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Henryk Barthel, John Seibyl, Adriaan A. Lammertsma, Victor L Villemagne, Osama Sabri

Journal of Nuclear Medicine May 2020, jnumed.119.228346; DOI: 10.2967/jnumed.119.228346

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Exploiting the Full Potential of Beta-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Henryk Barthel, John Seibyl, Adriaan A. Lammertsma, Victor L Villemagne, Osama Sabri

Journal of Nuclear Medicine May 2020, jnumed.119.228346; DOI: 10.2967/jnumed.119.228346

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease

Google Scholar

Hot Topics (Invitation Only)

The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors
Tackling the Last Mile: A major component to successfully establish radioligand therapy
Whole-Body PET Imaging: A Catalyst for Whole-Person Research?

Show more Hot Topics (Invitation Only)

Clinical (Neurology)

Tau PET Visual Reads: Research and Clinical Applications and Future Directions
Diagnostic utility of amino acid PET in the differential diagnosis of recurrent brain metastases and treatment-related changes: a meta-analysis
The association of age-related and off-target retention with longitudinal quantification of [¹⁸F]MK6240 tau-PET in target regions.

Show more Clinical (Neurology)

Keywords

Neurology
Alzheimer
amyloid
Drugs
PET
Tau

Main menu

User menu

Search

Exploiting the Full Potential of Beta-Amyloid and Tau PET Imaging for Drug Efficacy Testing

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Hot Topics (Invitation Only)

Clinical (Neurology)

Similar Articles

Keywords